Project Details
| Short title | APM001 |
|---|---|
| Status | Active |
| Effective start/end date | 10/09/20 → 29/07/25 |
A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, 60-Week, Phase II Clinical Trial of Three Re-Purposed Medications in Moderate Severity Parkinson’s Disease
- Rowe, Dominic (Primary Chief Investigator)
- Gan, Richard (Research Coordinator)
Project: Research